Tailored Management Needed for Male Patients With NSCLC After ...

Demonstrated differences in outcomes between female and male patients in the perioperative setting for non–small cell lung cancer (NSCLC) ...

Maggie L. Shaw - American Journal of Managed Care

Tailored Management Needed for Male Patients With NSCLC After Surgery · Maggie L. Shaw · Lung cancer is the top cause of cancer-related death worldwide.

Current landscape and tailored management of immune-related ...

These initial findings are required to be ... Lower survival in patients who develop pneumonitis following immunotherapy for lung cancer.

Tailoring Treatment for Patients With NSCLC Eligible for Biomarker ...

The rapidly expanding treatment landscape for NSCLC is enabling individualized treatment decision-making and improving patient outcomes.

Personalized Treatment for Patients With Lung Cancer - PMC

In patients with locally advanced SCLC, clinical stage “limited disease” (classification of the Veterans Administration Lung Study Group [VALG]), so long as the ...

P2.17A.01 Treatment Outcomes after Access to Broad Molecular ...

01 Treatment Outcomes after Access to Broad Molecular Tests, Targeted Agents and Immunotherapy in NSCLC Patients from Brazil ... Tailored management of metastatic ...

Non-Small Cell Lung Cancer Treatment (PDQ®) - NCI

These results indicate that patient survival following resection for NSCLC is associated with the number of lymph nodes evaluated during surgery ...

Advanced NSCLC: Tailoring Treatment to the Patient

The goal of this activity is to present real-life situations in which key treatment decisions, including the use of chemotherapy and targeted therapy as first- ...

Physiotherapy management of lung cancer - ScienceDirect.com

Physiotherapists play an important role in the management of people with lung cancer. ... Example clinical pathway for patients after thoracotomy. Day 1 ...

Tailored Therapy for Stage I Non–Small-Cell Lung Cancer

surgical management of NSCLC clearly defines the physiologic re- serve and lung function criteria needed for patients to undergo major lung ...

A 90-day mortality risk model as a support in managing patients ...

Thus, it is crucial to know the incidence of postoperative complications and deaths after VATS resection of lung cancer in order to better counsel the ...

Optimizing Outcomes in ALS: Patient Perspectives, Diagnostic ...

Optimizing Outcomes in ALS: Patient Perspectives, Diagnostic Essentials, and Tailored Management Approaches · Activity Snapshot · Faculty · Agenda · Learning ...

Management of Male Breast Cancer: ASCO Guideline Summary

Tamoxifen is recommended as first-line endocrine therapy for men in the adjuvant and advanced/metastatic settings. Testing for inherited predisposing risk ...

Social Media Dressed For The Occasion? - Tailored Management

Writing Your BIO. Be authentic and personable. Draw people in, and engage them enough to read your entire profile. Your bio is your first impression, so put ...

Optimizing the Role of Oncology Pharmacists in Outpatient Care for ...

Tailored Management Needed for Male Patients With NSCLC After Surgery · article cover. ajmc.com1 day ago. Read in NewsBreak · Alameda Hospital ...

Sex differences in adverse events among cancer patients receiving ...

The analysis observed a not statistically significant difference in terms of immune-related adverse events (irAEs) between males and females ( ...

ASTRO Radiation Therapy Summary of the ASCO Guideline on ...

Approximately 30% to 55% of patients develop locoregional failures following resection for node-positive NSCLC, and locoregional failure will occur as an ...

Recent updates of precision therapy for gastric cancer

Recent updates of precision therapy for gastric cancer: Towards optimal tailored management. ... tailored therapy for individual patients. Since the report ...

Tagrisso with the addition of chemotherapy approved in the US for ...

Patients with EGFRm NSCLC are particularly sensitive to treatment with an EGFR-tyrosine kinase inhibitor (EGFR-TKI) which blocks the cell- ...

Amivantamab plus chemotherapy with and without lazertinib in ...

A total of 657 patients with EGFR-mutated (exon 19 deletions or L858R) locally advanced or metastatic NSCLC after disease progression on ...